GBE1 and adult polyglucosan body disease: A previous study testing a gene therapy approach for APBD demonstrated that intravenous injection of AAV9-mediated human GBE1 into 14-day-old APBD mice [8] resulted in a significant increase in GBE1 enzyme activity in the brain, skeletal muscle, and heart at 3 months of age [12].